ROYALTY PHARMA HOLDINGS LTD

Active Bristol

Other service activities n.e.c.

0 employees website.com
Life sciences and medical technology Other service activities n.e.c.
R

ROYALTY PHARMA HOLDINGS LTD

Other service activities n.e.c.

Founded 10 Feb 2020 Active Bristol, England 0 employees website.com
Life sciences and medical technology Other service activities n.e.c.
Accounts Due 30 Sept 2026 5 months remaining
Confirmation Submitted 21 Feb 2026 Next due 19 Feb 2027 9 months remaining
Net assets £7,311M £489M 2024 year on year
Total assets £13,565M £1,887M 2024 year on year
Total Liabilities £6,254M £1,398M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Pavilions Bridgwater Road Bristol BS13 8AE England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ROYALTY PHARMA HOLDINGS LTD (12453789), an active life sciences and medical technology company based in Bristol, England. Incorporated 10 Feb 2020. Other service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2020–2024)

Cash in Bank

£40.43M

Increased by £9.82M (+32%)

Net Assets

£7310.72M

Increased by £489.01M (+7%)

Total Liabilities

£6254.26M

Increased by £1398.43M (+29%)

Turnover

£1245.29M

Decreased by £291.09M (-19%)

Employees

N/A

Debt Ratio

46%

Increased by 4 (+10%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

19 Allotments 634,616 Shares £63.721 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Feb 2026332,825$33.283$0
13 Jan 20265,312$0.531$0
31 Dec 2025967$0.097$0
19 Dec 20252,125$0.213$0
16 Dec 202545,596$4.56$0

Officers

Officers

2 active 1 resigned
Status
George Wingate LloydDirectorAmericanUnited States6610 Jun 2020Active
Mcgivern, ArthurDirectorAmericanUnited States501 Jan 2026Active

Shareholders

Shareholders (6)

Gtu Ops Inc
84.7%
536,192,971
Royalty Pharma Plc
8.8%
55,661,403

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Royalty Pharma Plc

United Kingdom

Active
Notified 10 Feb 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

ROYALTY PHARMA PLC united kingdom
ROYALTY PHARMA HOLDINGS LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Mar 2026CapitalCapital Name Of Class Of Shares
23 Feb 2026CapitalAllotment of shares (USD 63,312.5911) on 2026-02-11
21 Feb 2026Confirmation StatementConfirmation statement made on 2026-02-05 with updates
20 Jan 2026CapitalAllotment of shares (USD 63,279.3086) on 2026-01-13
16 Jan 2026OfficersAppointment of Mr Arthur Mcgivern as director on 2026-01-01
3 Mar 2026 Capital

Capital Name Of Class Of Shares

23 Feb 2026 Capital

Allotment of shares (USD 63,312.5911) on 2026-02-11

21 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-02-05 with updates

20 Jan 2026 Capital

Allotment of shares (USD 63,279.3086) on 2026-01-13

16 Jan 2026 Officers

Appointment of Mr Arthur Mcgivern as director on 2026-01-01

Recent Activity

Latest Activity

Capital Name Of Class Of Shares

1 months ago on 3 Mar 2026

Allotment of shares (USD 63,312.5911) on 2026-02-11

2 months ago on 23 Feb 2026

Confirmation statement made on 2026-02-05 with updates

2 months ago on 21 Feb 2026

Allotment of shares (USD 63,279.3086) on 2026-01-13

3 months ago on 20 Jan 2026

Appointment of Mr Arthur Mcgivern as director on 2026-01-01

3 months ago on 16 Jan 2026